Form 4: Palisade Bio Director Margery B. Fischbein Acquires 2,100 Stock Options
SEC Form 4
Director Margery B. Fischbein acquired 2,100 common stock options in Palisade Bio, Inc. as part of director compensation.
Summary
- Margery B. Fischbein, a director of Palisade Bio, Inc. (PALI), acquired 2,100 common stock options on July 11, 2024.
- These options were granted as partial compensation for her services as a director, according to the Issuer's non-employee director compensation policy.
- The options were issued from Palisade Bio's 2021 Equity Incentive Plan.
- Each option allows the purchase of one share of common stock at an exercise price of $4.49.
- The options vest fully on the one-year anniversary of the grant date and expire on 07/11/2034.
- Following the transaction, Fischbein beneficially owns 2,100 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a standard compensation practice that aligns director interests with shareholders. There are no indications of negative news or concerns.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule encourages continued service by the director.
Future Outlook
NA
Industry Context
Stock option grants to directors are a common practice in the biotech industry to align their interests with shareholders and incentivize performance.
Comparison to Industry Standards
- Director compensation packages, including stock options, are typical in publicly traded companies, especially in the biotech sector.
- The specific number of options and vesting schedules vary based on company size, performance, and industry benchmarks.
- Comparing Palisade Bio's director compensation with similar-sized biotech companies would provide a better understanding of its competitiveness.
Stakeholder Impact
- The stock option grant could have a minor positive impact on shareholder sentiment as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of transaction: Fischbein acquired 2,100 common stock options. |
| 07/11/2024 | Grant date of the options. |
| One year anniversary of 07/11/2024 | Options vest fully. |
| 07/15/2024 | Date of signature on the Form 4. |
| 07/11/2034 | Expiration date of the options. |
Keywords
Palisade Bio, Director Compensation, Stock Options, Form 4, Equity Incentive Plan, Beneficial Ownership, Margery Fischbein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.